-The Hindu While Monsanto and Indian seed companies spar, more worrying is the confused lawmaking underpinning regulation of patents Genetically Modified Organisms (GMOs) breed controversy like no other. Little wonder then that Monsanto’s much-maligned Bt cotton has spawned the mother of all intellectual property (IP) disputes in India, involving at least 15 different proceedings in various courts, government agencies and tribunals at last count. Most proceedings appear to have come at the behest...

-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...

-The Hindu The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. Humanitarian aid organisation Médecins Sans Frontières (MSF) has warned India that the country will not remain ‘pharmacy of the developing world’ if the proposals in the Regional Comprehensive Economic Partnership agreement (RCEP) are adopted. The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. MSF Access Campaign...

-PTI India will need to front load its investments substantially to almost double the number of people on ARV treatment in less than five years, Minister for Health and Family Welfare, J P Nadda said at UNGA. United Nations: With over 80 per cent of the affordable and quality anti-retroviral drugs used globally to treat AIDS supplied by Indian pharmaceutical industry, India has sought flexibilities in IPR under a global trade...

-The Hindu Intellectual property accelerates innovation in certain technology sectors, but it impedes innovation in others. The biggest flaw of the new policy is that it does not acknowledge this. Intellectual property (IP) regimes suffer a classic paradox. While they attempt to encourage innovation and creativity, they have themselves been shielded from innovation experimentation. For some years now, India has been attempting to break this mould and craft a regime to suit...